Literature DB >> 8449967

Second-look laparotomies in ovarian cancer: a medical oncologist's perspective.

M Markman.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8449967     DOI： 10.1007/bf01208837

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  12 in total

1.  Leukemia following chemotherapy for ovarian cancer.

Authors:  J M Kaldor; N E Day; F Pettersson; E A Clarke; D Pedersen; W Mehnert; J Bell; H Høst; P Prior; S Karjalainen
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

2.  Second thoughts about second-look laparotomy in advanced ovarian cancer.

Authors:  J B Friedman; N S Weiss
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

3.  Evaluation of treatment and survival after positive second-look laparotomy.

Authors:  K C Podratz; M F Schray; H S Wieand; J H Edmonson; J A Jefferies; H J Long; G D Malkasian; C R Stanhope; T O Wilson
Journal:  Gynecol Oncol       Date:  1988-09       Impact factor: 5.482

4.  High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation.

Authors:  J Dauplat; M Legros; P Condat; J P Ferriere; S Ben Ahmed; R Plagne
Journal:  Gynecol Oncol       Date:  1989-09       Impact factor: 5.482

5.  Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.

Authors:  W J Hoskins; S C Rubin; E Dulaney; D Chapman; L Almadrones; P Saigo; M Markman; T Hakes; B Reichman; W B Jones
Journal:  Gynecol Oncol       Date:  1989-09       Impact factor: 5.482

6.  Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.

Authors:  S C Rubin; W J Hoskins; T B Hakes; M Markman; J M Cain; J L Lewis
Journal:  Am J Obstet Gynecol       Date:  1988-11       Impact factor: 8.661

7.  Long-term survival after chemotherapy for advanced epithelial ovarian carcinoma.

Authors:  J T Wharton; C L Edwards; F N Rutledge
Journal:  Am J Obstet Gynecol       Date:  1984-04-01       Impact factor: 8.661

8.  Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.

Authors:  M Markman; B Reichman; T Hakes; J L Lewis; W Jones; S Rubin; R Barakat; J Curtin; L Almadrones; W Hoskins
Journal:  J Clin Oncol       Date:  1992-09       Impact factor: 44.544

9.  Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.

Authors:  M H Greene; J D Boice; B E Greer; J A Blessing; A J Dembo
Journal:  N Engl J Med       Date:  1982-12-02       Impact factor: 91.245

10.  Poor survival of treatment-related acute nonlymphocytic leukemia.

Authors:  A I Neugut; E Robinson; J Nieves; T Murray; W Y Tsai
Journal:  JAMA       Date:  1990 Aug 22-29       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.